News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,431 Results
Type
Article (53876)
Company Profile (330)
Press Release (710215)
Multimedia
Podcasts (113)
Webinars (20)
Section
Business (215472)
Career Advice (2870)
Deals (37068)
Drug Delivery (128)
Drug Development (86177)
Employer Resources (185)
FDA (17221)
Job Trends (15900)
News (366245)
Policy (35551)
Tag
Academia (2910)
Academic (1)
Accelerated approval (16)
Adcomms (33)
Allergies (127)
Alliances (52750)
ALS (146)
Alzheimer's disease (1664)
Antibody-drug conjugate (ADC) (248)
Approvals (17267)
Artificial intelligence (440)
Autoimmune disease (90)
Automation (29)
Bankruptcy (388)
Best Places to Work (12181)
BIOSECURE Act (22)
Biosimilars (161)
Biotechnology (217)
Bladder cancer (136)
Brain cancer (51)
Breast cancer (511)
Cancer (4028)
Cardiovascular disease (341)
Career advice (2423)
Career pathing (36)
CAR-T (240)
CDC (53)
Cell therapy (652)
Cervical cancer (32)
Clinical research (71928)
Collaboration (1399)
Company closure (4)
Compensation (930)
Complete response letters (56)
COVID-19 (2887)
CRISPR (81)
C-suite (609)
Cystic fibrosis (135)
Data (4736)
Decentralized trials (2)
Denatured (34)
Depression (109)
Diabetes (447)
Diagnostics (6899)
Digital health (35)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (204)
Drug pricing (185)
Drug shortages (31)
Duchenne muscular dystrophy (204)
Earnings (90768)
Editorial (54)
Employer branding (23)
Employer resources (162)
Events (121990)
Executive appointments (988)
FDA (19735)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1248)
Gene editing (172)
Generative AI (37)
Gene therapy (530)
GLP-1 (982)
Government (5092)
Grass and pollen (8)
Guidances (370)
Healthcare (20092)
HIV (46)
Huntington's disease (38)
IgA nephropathy (63)
Immunology and inflammation (243)
Immuno-oncology (22)
Indications (58)
Infectious disease (3127)
Inflammatory bowel disease (185)
Inflation Reduction Act (16)
Influenza (97)
Intellectual property (193)
Interviews (558)
IPO (17045)
IRA (57)
Job creations (4085)
Job search strategy (1982)
Kidney cancer (17)
Labor market (74)
Layoffs (604)
Leadership (35)
Legal (8743)
Liver cancer (92)
Longevity (12)
Lung cancer (583)
Lymphoma (267)
Machine learning (30)
Management (63)
Manufacturing (621)
MASH (144)
Medical device (14248)
Medtech (14273)
Mergers & acquisitions (20910)
Metabolic disorders (1127)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (225)
Neuropsychiatric disorders (60)
Neuroscience (2700)
NextGen: Class of 2025 (7124)
Non-profit (4901)
Now hiring (59)
Obesity (536)
Opinion (294)
Ovarian cancer (139)
Pain (167)
Pancreatic cancer (175)
Parkinson's disease (239)
Partnered (28)
Patents (419)
Patient recruitment (332)
Peanut (57)
People (62981)
Pharmaceutical (71)
Pharmacy benefit managers (27)
Phase I (22347)
Phase II (31524)
Phase III (23592)
Pipeline (2785)
Policy (286)
Postmarket research (2914)
Preclinical (9602)
Press Release (70)
Prostate cancer (200)
Psychedelics (52)
Radiopharmaceuticals (268)
Rare diseases (672)
Real estate (6424)
Recruiting (76)
Regulatory (25334)
Reports (52)
Research institute (2590)
Resumes & cover letters (454)
Rett syndrome (16)
RNA editing (15)
RSV (72)
Schizophrenia (138)
Series A (206)
Series B (156)
Service/supplier (15)
Sickle cell disease (80)
Special edition (23)
Spinal muscular atrophy (162)
Sponsored (38)
Startups (3902)
State (2)
Stomach cancer (17)
Supply chain (99)
Tariffs (91)
The Weekly (77)
Vaccines (1012)
Venture capital (66)
Weight loss (368)
Women's health (56)
Worklife (20)
Date
Last 7 days (763)
Last 30 days (2590)
Last 365 days (31673)
2025 (26365)
2024 (36637)
2023 (41550)
2022 (52767)
2021 (57460)
2020 (56293)
2019 (49536)
2018 (37488)
2017 (34299)
2016 (34174)
2015 (40235)
2014 (34166)
2013 (29547)
2012 (31643)
2011 (32177)
2010 (30394)
Location
Africa (923)
Alabama (74)
Alaska (7)
Arizona (280)
Arkansas (14)
Asia (43085)
Australia (7856)
California (9511)
Canada (2885)
China (909)
Colorado (397)
Connecticut (408)
Delaware (269)
Europe (95900)
Florida (1410)
Georgia (310)
Hawaii (2)
Idaho (64)
Illinois (764)
India (52)
Indiana (463)
Iowa (19)
Japan (328)
Kansas (122)
Kentucky (36)
Louisiana (18)
Maine (68)
Maryland (1261)
Massachusetts (6984)
Michigan (290)
Minnesota (561)
Mississippi (4)
Missouri (120)
Montana (31)
Nebraska (25)
Nevada (106)
New Hampshire (78)
New Jersey (2612)
New Mexico (30)
New York (2578)
North Carolina (1344)
North Dakota (9)
Northern California (4425)
Ohio (291)
Oklahoma (20)
Oregon (41)
Pennsylvania (1992)
Puerto Rico (20)
Rhode Island (45)
South America (1295)
South Carolina (50)
South Dakota (1)
Southern California (3653)
Tennessee (151)
Texas (1471)
United States (34654)
Utah (284)
Virginia (230)
Washington D.C. (83)
Washington State (800)
West Virginia (4)
Wisconsin (83)
Wyoming (1)
764,431 Results for "taconic biosciences formerly known as taconic farms inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Taconic and Cyagen Collaborate to Streamline Access to Preclinical Mouse and Rat Models
August 5, 2025
·
3 min read
Press Releases
Taconic Biosciences Enters Into an Exclusive License Agreement With Helmholtz Munich to Expand Its CRISPR/Cas9 Gene Editing Services
June 9, 2025
·
2 min read
IN PARTNERSHIP WITH TACONIC BIOSCIENCES
The ‘Research Safety Net’ Saving Scientists from Funding Crisis
In this episode presented by Taconic Biosciences, BioSpace’s head of insights Lori Ellis discusses how preclinical research companies are helping drug developers navigate the current challenging funding environment with Mike Garrett, CEO.
September 4, 2025
·
1 min read
·
Lori Ellis
Press Releases
Taconic Biosciences Announces New U.S. West Coast Production Location
November 21, 2024
·
2 min read
Deals
H.I.G. Capital Completes Sale of Taconic Biosciences
H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $52 billion of equity capital under management, is pleased to announce the sale of its portfolio company Taconic Biosciences (“Taconic” or the “Company”) to Avista Capital Partners (“Avista”).
November 1, 2022
·
4 min read
Press Releases
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
September 12, 2025
·
4 min read
Metabolic disorders
Ascendis Skids as FDA Detects Death in Patient Formerly on Yorvipath
The death occurred in a patient who had a complex medical background and who was being managed with several drugs, according to RBC Capital.
October 21, 2025
·
2 min read
·
Tristan Manalac
Deals
Avista Capital Partners Acquires Taconic Biosciences
Avista Capital Partners, a leading private equity firm focused exclusively on healthcare, announced its acquisition of Taconic Biosciences, a leading provider of genetically engineered research models and related services, from H.I.G. Capital.
November 1, 2022
·
3 min read
Pharm Country
Taconic Biosciences Launches First and Only Super Immunodeficient Mouse Models Lacking Residual Murine Fc Gamma Receptors, for Improved Antibody Therapy Assessment
Taconic Biosciences has launched the FcResolv™ NOG portfolio, the first and only super immunodeficient mouse models lacking residual murine Fc gamma receptors known to confound results in antibody-based therapy studies.
October 24, 2022
·
2 min read
Venture capital
Building Pharma’s Farm System: Eli Lilly, Boehringer Ingelheim, More Invest in the Future
While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and venture funds to uncover cutting-edge scientific trends, determine their future focus points and even carve out a niche in an emerging geographical hotspot.
August 6, 2025
·
5 min read
·
Heather McKenzie
1 of 76,444
Next
